Simbol bursier DVAX - Dynavax Technologies Corp.

Simbol DVAX
Dynavax Technologies Corp.

sâmbătă, 21 decembrie 2024, ora 16:13:13 EEST (UTC + 3)

Simbol DVAX
Simbol	DVAX
Simbol eToro	DVAX
MarketWatch	DVAX
Finviz	DVAX
Yahoo Finance	DVAX
Google Finance	DVAX
TradingView	DVAX
Investing.com	DVAX
Denumire	Dynavax Technologies Corp.
Website	dynavax.com
Piața	NASDAQ
ISIN	US2681582019
Sector	Health Technology
Industrie	Biotechnology
Monedă	USD
Preț	13,6400 USD
Capitalizare bursieră	1,760 mld. USD
P/E	35,53
Beta	1,4443
EPS	0,3839
Profit anual	+24,91%
Dată actualizare	18.12.2023

Descriere

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

Istoric cotații

Data	P/E	Beta	Capitalizare	Dividend	EPS	Profit anual	Preț
23.09.2021	0,00	1,0783	2,160	0,00%	-0,2664	+313,25%	$0,00
28.04.2023	5,29	1,3733	1,330	0,00%	1,9677	+11,25%	$10,41
23.06.2023	8,31	1,4237	1,670	0,00%	1,5612	+3,70%	$12,98
20.11.2023	35,63	1,4301	1,770	0,00%	0,3839	+7,05%	$13,68
18.12.2023	35,53	1,4443	1,760	0,00%	0,3839	+24,91%	$13,64

Pagină vizualizată de 120 ori și generată în 0,029533 secunde.

Simbol DVAXDynavax Technologies Corp.

Istoric cotații

Simbol DVAX
Dynavax Technologies Corp.